Condition category
Musculoskeletal Diseases
Date applied
Date assigned
Last edited
Prospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Chronic back pain is defined as pain that persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain has been treated. About 20 per cent of people affected by acute low back pain develop chronic low back pain with persistent symptoms at one year. In some cases, treatment successfully relieves chronic low back pain, but in other cases pain persists despite medical and surgical treatment. Shock wave therapy is a procedure where shock waves are passed through the skin to the affected area using a special device, and ultrasound guidance may be used.
The aim of this study is to assess the effectiveness of Radial Shock Wave Therapy (RSWT) and Focused Shock Wave Therapy (FSWT) and to compare real procedures to sham procedures in the treatment of low back pain. These two types of Extracorporeal Shock Wave Therapy were chosen because of the differences in tissues penetration. Both are increasingly used to treat patients with low back pain, but there was no reliable research that assessed which one is more effective.

Who can participate?

Patients aged 18 and over, both males and females, with chronic low back pain.

What does the study involve?

Participants are randomly allocated to receive RSWT, FSWT, sham RSWT or sham FSWT, 10 times in total. Pain relief and functional improvement are measured before and after treatment and during follow-up visits 1 and 3 months after the end of the study.

What are the possible benefits and risks of participating?

Participants will receive a complete treatment program, which may lead to reduced pain and functional improvement. 
Risks include temporary pain up to 24 hours after the shock wave procedure.

Where is the study run from?

Opole Medical School (Poland)

When is the study starting and how long is it expected to run for?
June 2018 to August 2020

Who is the main contact?
1. Dr Katarzyna Rajfur
2. Prof. Jakub Taradaj

Trial website

Contact information



Primary contact

Dr Katarzyna Rajfur


Contact details

68 Katowicka Street
+48 (0)506202372



Additional contact

Prof Jakub Taradaj


Contact details

Mikołowska 72B Street
+48 (0)668613945

Additional identifiers

EudraCT number

Nil known number

Nil known

Protocol/serial number


Study information

Scientific title

Long and short term clinical, functional and postural outcomes of radial vs. focused extracorporeal shock wave therapy in patients with chronic low back pain


Study hypothesis

1. Both Radial Shock Wave Therapy (RSWT) and Focused Shock Wave Therapy (FSWT) are effective in pain relief in patients with chronic low back pain

2. The RSWT and FSWT are effective in functional improvement in individuals with chronic low back pain

3. Both RSWT and FSWT improve postural control in subjects with chronic low back pain

4. The RSWT and FSWT improve gait parameters in participants with chronic low back pain
5. According to biological and physical mechanisms, it seams the FSWT promote more effective clinical, functional and postural outcomes compared to the RSWT

Ethics approval

Approved 13/08/2018, Research Ethics Committee from Opole Medical School (68 Katowicka Street; 45-065; Poland; +48 774410882;, ref: KB/90/FI/2018

Study design

Prospective randomized single-blinded study with follow-up analysis

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet


Chronic low back pain


After baseline assessments, the participants will be randomly assigned to:
1. FESWT and core stability exercises, or
2. RESWT and core stability exercises, or
3. Sham FESWT and core stability exercises, or
4. Sham RESWT and core stability exercises

The individuals receiving the treatment will be blinded. A computer-generated list of random numbers will be used and concealed from the researchers enrolling and assessing the participants. The outcome assessors and data analysts will be kept blinded to the allocation

The treatment protocol will include core stability training (45 minutes, once a day, five days a week from Monday to Friday) with myofascial relaxation of the erector spinae, activation of the lumbo-pelvic-hip complex and deep muscles, stimulation of proper breathing, dynamic postural exercises, and treatment with RESWT (2 000 shots each session; energy flux density of 0.1 mJ/mm2; frequency of 5 Hz) using a pneumatic device in group A, or treatment with FESWT (1 000 shots each session; energy flux density of 0.15 mJ/mm2; frequency of 4 H) using an ultrasound device in group B. The procedures were performed twice a week (Monday and Thursday) for a period of five weeks (10 procedures in total).

Participants in group C and D were treated with the same core stability training compared to previous groups and additionally with the sham physical procedures. The shock wave therapy was identical to that of group A and B (the sham stimulation was voided of biologically active components by applying a special polyethylene applicator cap, which absorbed energy and limited its propagation to the human tissues) with the same sound signals during the procedure of the pneumatic/ultrasound head and the same technical parameters as in the real procedures.

Intervention type



Not Applicable

Drug names

Primary outcome measure

Pain assessed with the Visual-Analogue Scale and the Laitinen Pain Indicator Questionnaire at baseline, after treatment, and during follow-up visits at one and three months

Secondary outcome measures

Measured at baseline, after treatment, and during follow-up visits at one and three months:
1. Quality of life assessed with the Oswestry and Roland–Morris Disability Questionnaire
2. Posture stability with open and closed eyes measured using posturography
3. Gait analysed using medical treadmill
4. Mobility range in the hip joint on the side of the herniated disc in the course of spinal discopathy measured using the Lasèque test. The starting position is lying down on the back with both legs straight. The examiner then slowly lifts one of the patient’s legs while the knee is straight at the joint until pain occurs. The mobility range is measured in angle degrees using a goniometer
5. Mobility of the lumbosacral spine evaluated using the Schober test. While the patient is in a standing position, the examiner marks 2 points on the patient’s skin: at 10 cm above the line connecting the posterior superior iliac spines, and then at 5 cm below that line. The patient then slowly bends down as far as possible, while keeping the knees straight. The measurement is made using a tape measure. The obtained result is recorded with an accuracy of up to 0.5 cm

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Patients with discopathy of the L5-S1 spine segment with chronic pain lasting more than three months (diagnosis based on magnetic resonance imaging examination to determine the advancement of degenerative and inflammatory changes of the lumbar region [> Modic III])

Participant type


Age group




Target number of participants


Total final enrolment


Participant exclusion criteria

1. Acute low back pain
2. Sciatica episodes
3. Degenerative changes of cervical or thoracic region (individuals with lesions I° and II° according to Modic classification will not be excluded from the study, only degeneration III° will be a basis for exclusion)
4. Past fractures of the bone structures of the spine; spinal surgery
5. Cancer
6. Vertebra forward dislocation
7. Rheumatoid arthritis and ankylosing spondylitis
8. Cauda equina syndrome
9. Pregnancy
10. Acute and chronic cardiovascular diseases
11. Arrhythmia and pacemaker
12. Metal implants
13. Dermatological conditions in the area of ESWT application
14. Sensory deficits
15. Psychiatric disorders
16. Immunological diseases
17. Infections
18. Chronic drug use
19. Problems with the balance system
20. Central nervous system diseases

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

Opole Medical School
68 Katowicka Street

Sponsor information


Opole Medical School

Sponsor details

68 Katowicka Street
+48 (0)774423546

Sponsor type




Funder type

Not defined

Funder name

Opole Medical School

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Publications in peer-reviewed journals.

IPD sharing statement:
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request (

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

17/08/2020: Total final enrolment number added. 21/04/2020: The recruitment end date was changed from 30/05/2020 to 10/02/2020. 22/11/2019: Trial’s existence confirmed by Opole Medical School